Omeros | OMER - Bienes





Bienes Cambio Fecha
Adma Biologics USD 624.24M 55.56M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Cytokinetics USD 1.42B 12.02M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Immunic USD 40.7M 20.72M 2025-09
Insmed USD 2.26B 96.18M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Rockwell Medical USD 52.62M 1.34M 2025-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
United Therapeutics USD 7.88B 528.9M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Xoma USD 263.15M 39.7M 2025-09